The Income & Growth VCT Market Cap ($2.25 Million)
Market Cap & Net Worth: The Income & Growth VCT (IGV)
The Income & Growth VCT market cap. The Income & Growth VCT (LSE:IGV) has a market capitalization of $2.25 Million (GBX18.48 Billion) as of November 4, 2026. Listed on the LSE stock exchange, this UK-based company holds position #29901 globally and #661 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Income & Growth VCT's stock price GBX57.00 by its total outstanding shares 324196992 (324.20 Million). Also see IGV operating cash flow for how efficiently the company converts equity into cash flow.
The Income & Growth VCT Market Cap History (2015–2026)
The Income & Growth VCT market cap history from 2015 to 2026. Data shows growth from $1.37 Million to $2.25 Million (5.45% CAGR). Check IGV stock price for real-time trading data and today's change.
The Income & Growth VCT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Income & Growth VCT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore The Income & Growth VCT annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.62x
The Income & Growth VCT's market cap is 0.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.76x
The Income & Growth VCT's market cap is 0.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.20 Million | $3.44 Million | $3.05 Million | 0.35x | 0.39x |
| 2017 | $1.18 Million | $4.21 Million | $3.79 Million | 0.28x | 0.31x |
| 2018 | $1.24 Million | $3.06 Million | $2.61 Million | 0.41x | 0.48x |
| 2019 | $1.43 Million | $6.28 Million | $5.85 Million | 0.23x | 0.24x |
| 2020 | $1.70 Million | $11.67 Million | $11.15 Million | 0.15x | 0.15x |
| 2021 | $2.59 Million | $42.30 Million | $41.86 Million | 0.06x | 0.06x |
| 2022 | $2.35 Million | $-10.66 Million | -$11.20 Million | -0.22x | N/A |
| 2023 | $2.42 Million | $6.09 Million | $5.49 Million | 0.40x | 0.44x |
| 2024 | $2.60 Million | $4.43 Million | $995.42K | 0.59x | 2.62x |
| 2025 | $2.41 Million | $3.86 Million | $3.18 Million | 0.62x | 0.76x |
Competitor Companies of IGV by Market Capitalization
Companies near The Income & Growth VCT in the global market cap rankings as of November 4, 2026. Also see IGV asset base for a full breakdown of the balance sheet.
Key companies related to The Income & Growth VCT by market ranking:
- Plaza Centers NV (WAR:PLZ): Ranked #29892 globally with a market cap of $2.26 Million USD ( zł8.23 Million PLN).
- Rockwood Realisation PLC (LSE:RKW): Ranked #29893 globally with a market cap of $2.26 Million USD ( GBX18.61 Billion GBX).
- Cyclerion Therapeutics Inc (NASDAQ:CYCN): Ranked #29902 globally with a market cap of $2.25 Million USD.
- BioNexus Gene Lab Corp Common stock (NASDAQ:BGLC): Ranked #29903 globally with a market cap of $2.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #29892 | Plaza Centers NV | WAR:PLZ | $2.26 Million | zł1.20 |
| #29893 | Rockwood Realisation PLC | LSE:RKW | $2.26 Million | GBX305.00 |
| #29902 | Cyclerion Therapeutics Inc | NASDAQ:CYCN | $2.25 Million | $23.94 |
| #29903 | BioNexus Gene Lab Corp Common stock | NASDAQ:BGLC | $2.25 Million | $0.95 |
Market Capitalization of The Income & Growth VCT (2015–2026)
Market capitalization of The Income & Growth VCT from 2015 to today. Between 2015 and today, The Income & Growth VCT's market cap moved from $1.37 Million to $ 2.25 Million, with a yearly change of 5.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX2.25 Million | -6.56% |
| 2025 | GBX2.41 Million | -7.58% |
| 2024 | GBX2.60 Million | +7.60% |
| 2023 | GBX2.42 Million | +2.85% |
| 2022 | GBX2.35 Million | -9.32% |
| 2021 | GBX2.59 Million | +52.99% |
| 2020 | GBX1.70 Million | +18.30% |
| 2019 | GBX1.43 Million | +15.15% |
| 2018 | GBX1.24 Million | +5.84% |
| 2017 | GBX1.18 Million | -2.26% |
| 2016 | GBX1.20 Million | -12.05% |
| 2015 | GBX1.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of The Income & Growth VCT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.25 Million USD |
| MoneyControl | $2.25 Million USD |
| MarketWatch | $2.25 Million USD |
| marketcap.company | $2.25 Million USD |
| Reuters | $2.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About The Income & Growth VCT
The Income & Growth VCT plc is a venture capital trust. It invests in companies at various stages of development. The fund invests in unquoted and new and secondary issues of quoted companies, which already have a trading facility on the Alternative Investment Market or on OFEX. It primarily makes investments in support services, software and computer services and general retailers. It prefers to… Read more